Optimising next-generation oncology treatments with companion diagnostics

By Kevin Robinson | Published: 23-Jun-2025
Analysis

With tissue-based companion diagnostics (CDx) emerging as critical tools to precisely match patients to advanced treatments, cancer treatment has been revolutionised by the emergence of targeted therapies

You need to be a subscriber to read this article.
Click here to find out more.

Dr Kevin Robinson (KSR) spoke to Jessica Baumann (JB), Medical Director, Companion Diagnostics and Advanced Assays, Leica Biosystems (pictured), to find out how technologies like multiplexing, spatial profiling and AI are driving this evolution.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.
  • Companies:
  • Leica Biosystems
See more

You may also like

Analysis

Leica Biosystems launches ChromoPlex III Detection System

Read more
Leica Biosystems launches ChromoPlex III Detection System, streamlining chromogenic multiplex IHC for reproducible, digital-ready staining

Trending Articles

  1. Almac Group expands US analytical capacity with new stability chambers in Souderton, PA This $2 million investment builds on the multi-million-dollar expansion of global analytical services and reinforces Almac’s commitment to meeting growing client demand
  2. Shimadzu’s new UV-1900i Plus – smarter, faster UV-Vis spectrophotometer Next-generation model offers ultra-fast scans and versatile measurement modes
  3. Labtex Labtex is a specialist laboratory and process chemistry equipment solutions provider. A dynamic team of professionals with expertise in research and process development across a wide range of industries and disciplines.
  4. Agilent expands the Dako Omnis family with three new models to meet evolving pathology lab needs These new instruments provide labs with the flexibility to tailor their staining solutions according to volume, workflow and diagnostic requirements
  5. CARBOGEN AMCIS CARBOGEN AMCIS is a global Contract Development and Manufacturing Organization (CDMO) providing drug development and commercialization services to the pharmaceutical and biopharmaceutical industries at all stages of drug development.<br><br>Our capabilities include contract chemical process research and development, supply of Active Pharmaceutical Ingredients (APIs), and drug products for preclinical studies, clinical trials, and commercial use, as well as high-quality Cholesterol and Vitamin D analog products

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Analysis

Leica Biosystems launches ChromoPlex III Detection System

Leica Biosystems launches ChromoPlex III Detection System, streamlining chromogenic multiplex IHC for reproducible, digital-ready staining
You need to be a subscriber to read this article.
Click here to find out more.
Analysis

Improving ADC selection with AI-enabled assays

In this article, Dr Rob Monroe, Chief Medical Officer at Leica Biosystems, discusses how diagnostics companies are working with researchers to develop novel assays leveraging digital imaging and analysis to identify patients for treatment with specific ADCs
Research & Development

Leica introduces integrated imaging microhub

The system automates sample-finding, parameter-setting and focus constancy, replacing manual setup with a single button push, the company claims
Ingredients

Shimadzu’s new UV-1900i Plus – smarter, faster UV-Vis spectrophotometer

Next-generation model offers ultra-fast scans and versatile measurement modes
Analysis

Shimadzu introduces new features in UV-1900i Plus

Optimised optics and CPU deliver ultra-fast scans and precise trace-level detection
Analysis

Agilent expands the Dako Omnis family with three new models to meet evolving pathology lab needs

These new instruments provide labs with the flexibility to tailor their staining solutions according to volume, workflow and diagnostic requirements
Analysis

Almac Group expands US analytical capacity with new stability chambers in Souderton, PA

This $2 million investment builds on the multi-million-dollar expansion of global analytical services and reinforces Almac’s commitment to meeting growing client demand
Subscribe now